Virtus LifeSci Biotech Clinical Trials ETF
17 hedge funds and large institutions have $2.11M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 3 closing their positions.
Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$1.17M |
| 2 |
2
Comerica Bank
Dallas,
Texas
|
$8.24K |
| 3 |
3
Fidelity Investments
Boston,
Massachusetts
|
$350 |
